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inflammatory agent rapamycin. The other components of the
stents include the polymer coating and the metal stent itself. The
investigators concluded that hypersensitivity to DES is a real entity
that causes serious clinical sequelae, and they recommended
continuous vigilance and surveillance for any allergic reactions in
patients receiving DES.
The Kounis syndrome (3) was described 15 years ago as the
concurrence of acute coronary events with allergic or hypersensi-
tivity reactions as well as anaphylactic or anaphylactoid insults.
Arachidonic acid metabolites such as leukotrienes and thromboxane;
proteolytic enzymes such as chymase and tryptase; histamine and a
variety of cytokines and chemokines released during the activation
of various interrelated and interacting inflammatory cells such as
macrophages, T-lymphocytes, and mast cells have all been incrim-
inated to induce Kounis syndrome. Two variants of Kounis
syndrome have been described recently (4). The type I variant,
includes patients with normal coronary arteries and represents a
manifestation of endothelial dysfunction; the type II variant,
includes patients with culprit but quiescent preexisting atheroma-
tus disease. Causes of Kounis syndrome (5) include various
conditions, a variety of environmental exposures, and many drugs
such as antibiotics, contrast media, intravenous anesthetics, anal-
gesics, skin disinfectants, corticosteroids, thrombolytics, anti-
inflammatories, and antineoplastics. Antineoplastics capable of
inducing acute coronary syndrome (5) are the antimetabolite
5-fluorouracil (Adrucil, UpJohn Pharmaceuticals, Kalamazoo,
Michigan), its prodrug capecitabine (Xeloda, Roche Laboratories,
Nutley, New Jersey), the alkaloid cisplatin (Platinol, Bristol-Myers
Squibb, Princeton, New Jersey), the antimicrotubule paclitaxel
(Taxol, Bristol-Myers Squibb), the interleukin-2 agent denileukin
difitox (Ontak, Ligand Pharmaceuticals, San Diego, California),
the vinca alkaloids, and interferons.
All three components of DES could be responsible for inducing
allergic reactions and Kounis syndrome. Polymers, like those in
latex and vinyl gloves, have been reported to induce allergic
reactions and Kounis syndrome (6). Antineoplastics and anti-
inflammatory drugs can also induce Kounis syndrome (6). Patients
positive for allergic patch-test reactions to stent metal components
nickel and molybdenum appear to have increased rates of in-stent
thrombosis (7). The inflammatory cells found at autopsy to
infiltrate the intima, the media, and the adventitia in one of the
patients who died from in-stent thrombosis (8) were the same—
namely lymphocytes, plasma cells, macrophages, and eosinophils—
with those participating in the process of Kounis syndrome.
Indeed, the proportion of 262 cases of allergic reactions in 2
million DES insertions is very low, but it seems likely that some
cases might go unreported; thus, it is anticipated that many more
cases will be encountered in the coming years.
Responding, therefore, to the appeal of the RADAR (Research
on Adverse Drug events And Reports) project and until further
studies characterizing the incidence and the course of the reactions
and confirming or predicting the DES allergy are undertaken,
we recommend, especially in atopic individuals, the following:
1) careful history of adverse drug reactions and allergies in patients
receiving DES; 2) intradermal skin tests for every DES component
and desensitization strategies; 3) antibody testing including
enzyme-linked immunosorbent assay and radioallergosorbent test
for every DES component; 4) monitoring the levels of tryptase,
histamine, and arachidonic acid products immediately after the
allergic reaction appears; and 5) considering the use of cortico-
steroids and mast-cell stabilizers when the allergic reaction
appears. The latter have also abrogated late thrombotic events
experimentally (9).
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REPLY
We appreciate the letter by Dr. Kounis and colleagues that expands
upon our discussion of the literature on stent-associated hypersensi-
tivity (1). In conjunction with the RADAR (Research on Adverse
Drug events And Reports) project (2), we have started a protocol
that incorporates some of the suggestions of Dr. Kounis and
colleagues. This protocol includes skin tests to stent components
and laboratory tests. It also features a methodical approach to
dechallenge and rechallenge (3) for concomitant medication while
maintaining antiplatelet coverage. To refer patients, please contact
Dr. Marc Feldman, Associate Professor, Department of medicine,
University of Texas, San Antonio (E-mail: feldmanm@uthscsa.edu).
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Real-Time Intracardiac Echocardiographic
Imaging of the Posterior Left Atrial Wall
Contiguous to Anterior Wall of the Esophagus
In a recent issue of the Journal, Good et al. (1) reported that
esophageal location and movement during left atrial ablation can
be detected using a barium ingestion–digital cine-fluoroscopic
imaging technique. The disadvantages of the barium ingestion–
cine-fluoroscopic imaging technique, which they used in the
report, include; 1) no real-time imaging during energy delivery of
the left atrial posterior wall contiguous to the anterior esophageal
wall, which is the most important/only region to be imaged and
protected; 2) gaps in barium contrast of the entire esophageal
mucosa border that may provide misleading information of the
extent of contact along the contiguous posterior left atrial wall;
3) an active effect of barium ingestion on esophageal luminal
diameter and movement; and 4) risk of aspiration. In addition,
Figures 1A and 1B in the report (1) compare differing anteropos-
terior projections, creating the illusion of movement that should
have been confirmed with the same angled projection.
Intracardiac echocardiography (ICE) can provide real-time
imaging of the left atrial posterior wall contiguous to the anterior
esophageal wall during energy delivery for left atrial ablation (2).
Our ICE studies of esophageal imaging in more than 235 patients
showed that the left atrial posterior wall contiguous to the anterior
esophageal wall can be imaged in each case. This imaging
technique can provide real-time anatomic imaging of this region (3).
In addition to anatomic imaging of this region, the ablation catheter
tip location and creation of echogenic lesions can also be evaluated
during real-time ICE imaging (4). The ICE imaging can guide
changes in the energy-delivery strategy to protect the esophagus
from damage during ablation in this region and allow for safe
lesion delivery in closer proximity to the esophagus than can be
safely recommended with the barium ingestion–cine-fluoroscopic
imaging technique.
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REPLY
Our study (1) describes a simple, practical, and inexpensive
method to visualize the position of the esophagus in relation to the
left atrium during left atrial catheter ablation in real-time. We have
the following responses to the points raised by Dr. Ren and
colleagues:
1. Because the barium paste typically remains in the esophagus
for45 to 60 min, fluoroscopic imaging of the esophagus after
a barium swallow is indeed real-time, and the anterior part of
the esophagus is easily visualized.
2. Although there may be gaps in the continuity of mucosal
staining after barium is swallowed, one can usually simply
extrapolate from the more proximal to distal segments of the
esophagus.
3. Although it is possible that barium swallow may facilitate
esophageal peristalsis, patients swallow their own saliva during
procedures performed under conscious sedation. Furthermore,
as already discussed in our study (1) there was no correlation
between the prevalence and extent of esophageal peristalsis and
the amount of barium swallowed.
4. Aspiration has not occurred during or after barium swallow in
over 500 patients who underwent left atrial catheter ablation
under conscious sedation in our electrophysiology laboratory.
5. Figures 1A and 1B (1) are identical anteroposterior projections
randomly chosen from many examples of esophageal migration.
As seen in Figure 1 (1), there is marked migration of the
esophagus. This clearly is not an illusion.
Finally, we do not dispute that intracardiac echocardiography
also may be used for real-time monitoring of the esophagus.
However, we find the barium swallow to be much simpler and
practical than intracardiac echocardiography.
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